OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients—A BioCAPTURE Registry Study
E Haar, Sarah E. Thomas, J. M. P. A. van den Reek, et al.
Drugs & Aging (2022) Vol. 39, Iss. 9, pp. 715-727
Open Access | Times Cited: 12
E Haar, Sarah E. Thomas, J. M. P. A. van den Reek, et al.
Drugs & Aging (2022) Vol. 39, Iss. 9, pp. 715-727
Open Access | Times Cited: 12
Showing 12 citing articles:
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER – study)
Diego Orsini, Giacomo Caldarola, Annunziata Dattola, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 6
Diego Orsini, Giacomo Caldarola, Annunziata Dattola, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 6
Age and biologic survival in patients with moderate-to-severe psoriasis: A cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Oras Alabas, K.J. Mason, Z.Z.N. Yiu, et al.
British Journal of Dermatology (2025)
Closed Access
Oras Alabas, K.J. Mason, Z.Z.N. Yiu, et al.
British Journal of Dermatology (2025)
Closed Access
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Mitchell S. Davis, Riley K. Spencer, Chandler E. Johnson, et al.
Dermatology and Therapy (2023) Vol. 14, Iss. 1, pp. 15-30
Open Access | Times Cited: 7
Mitchell S. Davis, Riley K. Spencer, Chandler E. Johnson, et al.
Dermatology and Therapy (2023) Vol. 14, Iss. 1, pp. 15-30
Open Access | Times Cited: 7
The implications of exosomes in psoriasis: disease: emerging as new diagnostic markers and therapeutic targets
Zahra Akbari Jonoush, Roya Mahdavi, Masoumeh Farahani, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Zahra Akbari Jonoush, Roya Mahdavi, Masoumeh Farahani, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Age affects drug survival rates of interleukin (IL )‐17 and IL ‐23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi‐country, cohort study
Andrea Chiricozzi, Giulia Coscarella, L. Puig, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 11, pp. 2175-2185
Closed Access | Times Cited: 2
Andrea Chiricozzi, Giulia Coscarella, L. Puig, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 11, pp. 2175-2185
Closed Access | Times Cited: 2
Differentially Expressed Genes and Molecular Susceptibility to Human Age-Related Diseases
С. Г. Шихевич, И. В. Чадаева, Bato Khandaev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3996-3996
Open Access | Times Cited: 5
С. Г. Шихевич, И. В. Чадаева, Bato Khandaev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3996-3996
Open Access | Times Cited: 5
Extracellular vesicles: a comprehensive review of their roles as biomarkers and potential therapeutics in psoriasis and psoriatic arthritis
Louis J. Born, Amor Khachemoune
Clinical and Experimental Dermatology (2022) Vol. 48, Iss. 4, pp. 310-318
Open Access | Times Cited: 8
Louis J. Born, Amor Khachemoune
Clinical and Experimental Dermatology (2022) Vol. 48, Iss. 4, pp. 310-318
Open Access | Times Cited: 8
Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks
E Haar, J. M. P. A. van den Reek, Kristian Gaarn du Jardin, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv17752-adv17752
Open Access | Times Cited: 3
E Haar, J. M. P. A. van den Reek, Kristian Gaarn du Jardin, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv17752-adv17752
Open Access | Times Cited: 3
Therapy of PsO in Special Subsets of Patients
Antonella Di Cesare, Federica Ricceri, Elia Rosi, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2879-2879
Open Access | Times Cited: 4
Antonella Di Cesare, Federica Ricceri, Elia Rosi, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2879-2879
Open Access | Times Cited: 4
Comparative Treatment Persistence and Adherence to Endothelin Receptor Antagonists Among Patients with Pulmonary Arterial Hypertension in Japan: A Real-World Administrative Claims Database Study
Junichi Omura, Yogeshwar Makanji, Nobuhiro Tanabe, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 4, pp. 511-526
Open Access | Times Cited: 1
Junichi Omura, Yogeshwar Makanji, Nobuhiro Tanabe, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 4, pp. 511-526
Open Access | Times Cited: 1
Healthcare Provider Administration of Biologics for Patients with Plaque Psoriasis: Literature Review and Clinical Considerations.
Matthew Brunner, Keri Holyoak, Douglas DiRuggiero
PubMed (2023) Vol. 16, Iss. 12 Suppl 2, pp. S20-S25
Closed Access | Times Cited: 1
Matthew Brunner, Keri Holyoak, Douglas DiRuggiero
PubMed (2023) Vol. 16, Iss. 12 Suppl 2, pp. S20-S25
Closed Access | Times Cited: 1
Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older Patients
Renaud Felten, Éric Toussirot
Drugs & Aging (2023) Vol. 40, Iss. 12, pp. 1101-1112
Closed Access
Renaud Felten, Éric Toussirot
Drugs & Aging (2023) Vol. 40, Iss. 12, pp. 1101-1112
Closed Access
